PubMed=7154478; DOI=10.5980/jpnjurol1928.73.8_1019
Katsusuke Naito, Haruo Hisazumi, Mototsugu Kanokogi, Masahiro Katoh, Kazuyoshi Nakazima, Kenji Tsukahara, Tetsuji Kobayashi, Kyoichi Kuroda, Fujitsugu Matsubara;
Establishment of cell lines (KH-39, KN-41, and KW-103) from human kidney and bladder cancer and their characteristics.
Nihon Hinyokika Gakkai Zasshi 73:1019-1031(1982)

PubMed=8621251; DOI=10.1002/(SICI)1097-0215(19960503)66:3<322::AID-IJC9>3.0.CO;2-0
Yoshihiko Tomita, Vladimir Bilim, Takashi Kawasaki, Kota Takahashi, Ismail Okan, Kristinn Petur Magnusson, Klas G. Wiman;
Frequent expression of Bcl-2 in renal-cell carcinomas carrying wild-type p53.
Int. J. Cancer 66:322-325(1996)

PubMed=10723130; DOI=10.1038/sj.onc.1203449
Andrei Alimov, Maria Kost-Alimova, Jian Liu, Chun-De Li, Ulf S.R. Bergerheim, Stefan Imreh, George Klein, Eugene R. Zabarovsky;
Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma.
Oncogene 19:1392-1399(2000)

PubMed=10929426; DOI=10.1007/s002400000103
Ichiro Shintaku, Nobutoshi Kawagoe, Shigeru Yutani, Sakuo Hoshi, Seiichi Orikasa, Osamu Yoshizumi, Kyogo Itoh;
Expression of the SART1 tumor rejection antigen in renal cell carcinoma.
Urol. Res. 28:178-184(2000)

PubMed=27993170; DOI=10.1186/s12943-016-0565-8; PMCID=PMC5168717
Klaudia Klarysa Brodaczewska, Cezary Szczylik, Michal Fiedorowicz, Camillo Porta, Anna Malgorzata Czarnecka;
Choosing the right cell line for renal cell cancer research.
Mol. Cancer 15:83.1-83.15(2016)